drugset / Trial / NCT06313528

A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943

NCT06313528

Phase 1 Completed 85 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of the study is to look at the effect of the study drug compared to placebo on calorie intake, energy metabolism, and appetite. The study will last up to 6 months and may include up to 20 visits.

Timeline

Start
2024-03-20
Primary completion
2025-08-26
Completion
2025-08-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Retatrutide Protein / enzyme biologic Subcutaneous

Indications